Plain-English translation of NCT07355491 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are evaluating a new eye imaging device called the VG200D to see how accurately it measures different parts of the eye compared to an existing device called the Cirrus. The study will enroll people with normal eyes, glaucoma, retina disease, or corneal problems to compare how well both devices measure eye structures like the cornea, retina, and optic nerve.
Doctors need reliable eye imaging tools to diagnose and monitor conditions like glaucoma and retina disease. This study helps determine whether the new imaging device works just as well as the established device, so it can potentially become available for patient care.
You will come to one clinical study site in the United States and have your eyes scanned with both the new VG200D device and the standard Cirrus device on the same visit. The study compares how well each device measures eye structures like the cornea thickness, retinal layers, and optic nerve. The visit is straightforward—you'll receive standard eye imaging with both devices, and the researchers will analyze how similar the measurements are between them.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
Intalight, Inc
Collaborators
Illinois College of Optometry
Enrollment target
~120 participants
Started
December 2025
Primary completion
May 2026
Age range
22 Years and older
Last updated on clinicaltrials.gov in July 2026.